

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | respiratory chain complex IV assembly (GO:0008535) | 4.69245905 |
| 2 | proteasome assembly (GO:0043248) | 4.58168307 |
| 3 | presynaptic membrane assembly (GO:0097105) | 4.26916850 |
| 4 | cytochrome complex assembly (GO:0017004) | 4.09489451 |
| 5 | postsynaptic membrane organization (GO:0001941) | 4.09343213 |
| 6 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 4.04256031 |
| 7 | mannosylation (GO:0097502) | 4.01341494 |
| 8 | polyamine biosynthetic process (GO:0006596) | 4.00146715 |
| 9 | protein localization to cilium (GO:0061512) | 3.98670250 |
| 10 | DNA deamination (GO:0045006) | 3.88981455 |
| 11 | sympathetic nervous system development (GO:0048485) | 3.85028733 |
| 12 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 3.60108066 |
| 13 | presynaptic membrane organization (GO:0097090) | 3.55636583 |
| 14 | rRNA modification (GO:0000154) | 3.54106055 |
| 15 | ribosomal small subunit assembly (GO:0000028) | 3.42432888 |
| 16 | regulation of pigment cell differentiation (GO:0050932) | 3.41433050 |
| 17 | thrombin receptor signaling pathway (GO:0070493) | 3.34587523 |
| 18 | facial nerve structural organization (GO:0021612) | 3.34474549 |
| 19 | rRNA methylation (GO:0031167) | 3.27941006 |
| 20 | polyamine metabolic process (GO:0006595) | 3.26703778 |
| 21 | protein heterotetramerization (GO:0051290) | 3.26283119 |
| 22 | lymphoid progenitor cell differentiation (GO:0002320) | 3.24477402 |
| 23 | GPI anchor biosynthetic process (GO:0006506) | 3.21839869 |
| 24 | superoxide anion generation (GO:0042554) | 3.17653461 |
| 25 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 3.06340124 |
| 26 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.04571200 |
| 27 | neurofilament cytoskeleton organization (GO:0060052) | 3.03885297 |
| 28 | protein complex biogenesis (GO:0070271) | 2.99845011 |
| 29 | cytidine metabolic process (GO:0046087) | 2.99413168 |
| 30 | cytidine catabolic process (GO:0006216) | 2.99413168 |
| 31 | cytidine deamination (GO:0009972) | 2.99413168 |
| 32 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.99146560 |
| 33 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.97746234 |
| 34 | termination of RNA polymerase III transcription (GO:0006386) | 2.93361539 |
| 35 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.93361539 |
| 36 | neutrophil activation (GO:0042119) | 2.93257757 |
| 37 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.92624974 |
| 38 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.90276595 |
| 39 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.88843352 |
| 40 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.88736622 |
| 41 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.88036583 |
| 42 | regulation of platelet activation (GO:0010543) | 2.85599858 |
| 43 | androgen biosynthetic process (GO:0006702) | 2.83662817 |
| 44 | NADH dehydrogenase complex assembly (GO:0010257) | 2.83435186 |
| 45 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.83435186 |
| 46 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.83435186 |
| 47 | signal peptide processing (GO:0006465) | 2.82235014 |
| 48 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.82109661 |
| 49 | chaperone-mediated protein transport (GO:0072321) | 2.81871258 |
| 50 | centriole assembly (GO:0098534) | 2.81286019 |
| 51 | regulation of platelet aggregation (GO:0090330) | 2.80927449 |
| 52 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.79707753 |
| 53 | centriole replication (GO:0007099) | 2.78856374 |
| 54 | histone mRNA metabolic process (GO:0008334) | 2.77506888 |
| 55 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.76693484 |
| 56 | GPI anchor metabolic process (GO:0006505) | 2.76575250 |
| 57 | male meiosis (GO:0007140) | 2.76270124 |
| 58 | neuronal action potential propagation (GO:0019227) | 2.76098253 |
| 59 | dopamine transport (GO:0015872) | 2.75811468 |
| 60 | microtubule depolymerization (GO:0007019) | 2.74392499 |
| 61 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.74219019 |
| 62 | C-terminal protein lipidation (GO:0006501) | 2.73899350 |
| 63 | granulocyte activation (GO:0036230) | 2.73261373 |
| 64 | protein neddylation (GO:0045116) | 2.73188013 |
| 65 | positive regulation of mast cell activation (GO:0033005) | 2.72753454 |
| 66 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.71914918 |
| 67 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.71398660 |
| 68 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.70759266 |
| 69 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.70531511 |
| 70 | negative regulation of heart rate (GO:0010459) | 2.69428589 |
| 71 | cellular response to arsenic-containing substance (GO:0071243) | 2.68436116 |
| 72 | DNA double-strand break processing (GO:0000729) | 2.66487725 |
| 73 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.64457318 |
| 74 | negative regulation of ligase activity (GO:0051352) | 2.64129338 |
| 75 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.64129338 |
| 76 | protein K11-linked ubiquitination (GO:0070979) | 2.63874630 |
| 77 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 2.62597239 |
| 78 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.62279545 |
| 79 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.62093324 |
| 80 | DNA ligation (GO:0006266) | 2.61459209 |
| 81 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.60943519 |
| 82 | DNA demethylation (GO:0080111) | 2.59778489 |
| 83 | DNA-dependent DNA replication (GO:0006261) | 2.59589561 |
| 84 | platelet dense granule organization (GO:0060155) | 2.58557531 |
| 85 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.58396437 |
| 86 | peripheral nervous system neuron development (GO:0048935) | 2.57986687 |
| 87 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.56674197 |
| 88 | mitochondrial calcium ion transport (GO:0006851) | 2.56649814 |
| 89 | amine biosynthetic process (GO:0009309) | 2.56060159 |
| 90 | GMP metabolic process (GO:0046037) | 2.55291933 |
| 91 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.55283640 |
| 92 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.54478604 |
| 93 | positive regulation of ligase activity (GO:0051351) | 2.54269838 |
| 94 | developmental pigmentation (GO:0048066) | 2.53008455 |
| 95 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.52629314 |
| 96 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.52629314 |
| 97 | blood coagulation, intrinsic pathway (GO:0007597) | 2.52518062 |
| 98 | purine-containing compound salvage (GO:0043101) | 2.51758280 |
| 99 | methionine metabolic process (GO:0006555) | 2.51118405 |
| 100 | regulation of chronic inflammatory response (GO:0002676) | 2.50558034 |
| 101 | CENP-A containing nucleosome assembly (GO:0034080) | 2.49881767 |
| 102 | methionine biosynthetic process (GO:0009086) | 2.49553895 |
| 103 | positive regulation of granulocyte differentiation (GO:0030854) | 2.49132873 |
| 104 | negative regulation of norepinephrine secretion (GO:0010700) | 2.49009035 |
| 105 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.47673875 |
| 106 | GDP-mannose metabolic process (GO:0019673) | 2.47649888 |
| 107 | enteric nervous system development (GO:0048484) | 2.47052700 |
| 108 | GTP biosynthetic process (GO:0006183) | 2.46937420 |
| 109 | keratinocyte development (GO:0003334) | 2.46911163 |
| 110 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.46252746 |
| 111 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.46195637 |
| 112 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.46195637 |
| 113 | C-terminal protein amino acid modification (GO:0018410) | 2.46065320 |
| 114 | piRNA metabolic process (GO:0034587) | 2.45943727 |
| 115 | regulation of cilium movement (GO:0003352) | 2.45654724 |
| 116 | ribosomal small subunit biogenesis (GO:0042274) | 2.44835554 |
| 117 | intraciliary transport (GO:0042073) | 2.44796758 |
| 118 | adenosine receptor signaling pathway (GO:0001973) | 2.43933314 |
| 119 | neutrophil activation involved in immune response (GO:0002283) | 2.43868232 |
| 120 | generation of neurons (GO:0048699) | 2.42149907 |
| 121 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.41248859 |
| 122 | detection of bacterium (GO:0016045) | 2.40874809 |
| 123 | viral protein processing (GO:0019082) | 2.40442652 |
| 124 | cranial nerve structural organization (GO:0021604) | 2.40201528 |
| 125 | negative regulation of type 2 immune response (GO:0002829) | 2.40051145 |
| 126 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.39841519 |
| 127 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.39841519 |
| 128 | axonemal dynein complex assembly (GO:0070286) | 2.38907822 |
| 129 | axoneme assembly (GO:0035082) | 2.38871773 |
| 130 | regulation of immunoglobulin secretion (GO:0051023) | 2.38527644 |
| 131 | mature B cell differentiation involved in immune response (GO:0002313) | 2.38284533 |
| 132 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.37877711 |
| 133 | iron-sulfur cluster assembly (GO:0016226) | 2.37600515 |
| 134 | metallo-sulfur cluster assembly (GO:0031163) | 2.37600515 |
| 135 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.37510625 |
| 136 | tRNA methylation (GO:0030488) | 2.37210488 |
| 137 | protein deneddylation (GO:0000338) | 2.36844399 |
| 138 | reactive oxygen species biosynthetic process (GO:1903409) | 2.35964575 |
| 139 | cullin deneddylation (GO:0010388) | 2.35147818 |
| 140 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.35026718 |
| 141 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.35026718 |
| 142 | meiosis I (GO:0007127) | 2.33970705 |
| 143 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.33881047 |
| 144 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.33345355 |
| 145 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.32996131 |
| 146 | response to folic acid (GO:0051593) | 2.32965994 |
| 147 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.32940898 |
| 148 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.32349417 |
| 149 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.32076704 |
| 150 | positive regulation of macrophage differentiation (GO:0045651) | 2.31921681 |
| 151 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.31750266 |
| 152 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.30804713 |
| 153 | regulation of regulatory T cell differentiation (GO:0045589) | 2.30354682 |
| 154 | L-methionine biosynthetic process (GO:0071265) | 2.29823443 |
| 155 | amino acid salvage (GO:0043102) | 2.29823443 |
| 156 | L-methionine salvage (GO:0071267) | 2.29823443 |
| 157 | single strand break repair (GO:0000012) | 2.29810261 |
| 158 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.28548211 |
| 159 | mitochondrial DNA replication (GO:0006264) | 2.28287518 |
| 160 | histone mRNA catabolic process (GO:0071044) | 2.27926095 |
| 161 | mesonephros development (GO:0001823) | 2.25591755 |
| 162 | nucleoside diphosphate catabolic process (GO:0009134) | 2.24454415 |
| 163 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.23747277 |
| 164 | epithelial cilium movement (GO:0003351) | 2.22324442 |
| 165 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.21664769 |
| 166 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.21664769 |
| 167 | adenosine metabolic process (GO:0046085) | 2.21642626 |
| 168 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.20245673 |
| 169 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.20202650 |
| 170 | multicellular organism reproduction (GO:0032504) | 2.19116327 |
| 171 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.18857704 |
| 172 | sequestering of actin monomers (GO:0042989) | 2.18366193 |
| 173 | acrosome reaction (GO:0007340) | 2.17281713 |
| 174 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.15044322 |
| 175 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.15044322 |
| 176 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.15044322 |
| 177 | respiratory burst (GO:0045730) | 2.14590310 |
| 178 | 7-methylguanosine RNA capping (GO:0009452) | 2.14352871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.58743223 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.42333244 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.41218481 |
| 4 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.15942555 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.80230365 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.79604241 |
| 7 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.57123369 |
| 8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.55549907 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.53483314 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.48951619 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.46382927 |
| 12 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.44498112 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.39049449 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.35084693 |
| 15 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.34383555 |
| 16 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.29309562 |
| 17 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.16314894 |
| 18 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.14286992 |
| 19 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 2.11103108 |
| 20 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.08150965 |
| 21 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.04178578 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.94609407 |
| 23 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.93998171 |
| 24 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.92854387 |
| 25 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.88052333 |
| 26 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.85835673 |
| 27 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85402570 |
| 28 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.85170755 |
| 29 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.79422750 |
| 30 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.76065019 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.74540198 |
| 32 | VDR_22108803_ChIP-Seq_LS180_Human | 1.72555105 |
| 33 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.70628452 |
| 34 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.69052643 |
| 35 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.67975333 |
| 36 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.67015240 |
| 37 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.65151024 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.60738208 |
| 39 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.59601681 |
| 40 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.58019594 |
| 41 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.57475966 |
| 42 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.57144209 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.50993736 |
| 44 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.47782656 |
| 45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.47086820 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.46992789 |
| 47 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.46543558 |
| 48 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.45506077 |
| 49 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.45273373 |
| 50 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.43063144 |
| 51 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.41527305 |
| 52 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.41055407 |
| 53 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.40363218 |
| 54 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.39062502 |
| 55 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.38773231 |
| 56 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.37785909 |
| 57 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.37180076 |
| 58 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.36626397 |
| 59 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.36144725 |
| 60 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.36108174 |
| 61 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.36040231 |
| 62 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34793924 |
| 63 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.33689453 |
| 64 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.33276374 |
| 65 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.32748900 |
| 66 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.30074966 |
| 67 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.29864021 |
| 68 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29851390 |
| 69 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.29471278 |
| 70 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.28756847 |
| 71 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.28462556 |
| 72 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.28439466 |
| 73 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.27859309 |
| 74 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.27608505 |
| 75 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.27010300 |
| 76 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.26983122 |
| 77 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.26768234 |
| 78 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.26318301 |
| 79 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.26105124 |
| 80 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.26011337 |
| 81 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.25387415 |
| 82 | GATA3_26560356_Chip-Seq_TH2_Human | 1.25038292 |
| 83 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.23509063 |
| 84 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.21879359 |
| 85 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.21715907 |
| 86 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20441294 |
| 87 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19646090 |
| 88 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.18134634 |
| 89 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.17939776 |
| 90 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.16513863 |
| 91 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.16417629 |
| 92 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.16228413 |
| 93 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.16065509 |
| 94 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15937927 |
| 95 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15091427 |
| 96 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.14291370 |
| 97 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.14102531 |
| 98 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.13201624 |
| 99 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.12493118 |
| 100 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.10897545 |
| 101 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.10795220 |
| 102 | FUS_26573619_Chip-Seq_HEK293_Human | 1.10669952 |
| 103 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.10202757 |
| 104 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.09334254 |
| 105 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.09109375 |
| 106 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.08655675 |
| 107 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.08008912 |
| 108 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.07971172 |
| 109 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.07793141 |
| 110 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.07272088 |
| 111 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.05788219 |
| 112 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.05228764 |
| 113 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.04272519 |
| 114 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.03944413 |
| 115 | KDM2B_26808549_Chip-Seq_REH_Human | 1.02251294 |
| 116 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.01346931 |
| 117 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.00590316 |
| 118 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.00305548 |
| 119 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.00168668 |
| 120 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.00071265 |
| 121 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.99994247 |
| 122 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.99957956 |
| 123 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.99476393 |
| 124 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.99362562 |
| 125 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99328134 |
| 126 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.99105512 |
| 127 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98780921 |
| 128 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.97929753 |
| 129 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.97561936 |
| 130 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.97406227 |
| 131 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.97317552 |
| 132 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.96806395 |
| 133 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.96476883 |
| 134 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.95826231 |
| 135 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.95708560 |
| 136 | EWS_26573619_Chip-Seq_HEK293_Human | 0.95704079 |
| 137 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.95246727 |
| 138 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95100990 |
| 139 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.95019105 |
| 140 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.94895761 |
| 141 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.93603537 |
| 142 | AR_20517297_ChIP-Seq_VCAP_Human | 0.93509291 |
| 143 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.92758710 |
| 144 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92464795 |
| 145 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.92058897 |
| 146 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.92034128 |
| 147 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.91855398 |
| 148 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.91855398 |
| 149 | MYB_26560356_Chip-Seq_TH2_Human | 0.86866061 |
| 150 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.86526605 |
| 151 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.85891638 |
| 152 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.85886157 |
| 153 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.85502326 |
| 154 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.85502326 |
| 155 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.85332224 |
| 156 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85093504 |
| 157 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.83155339 |
| 158 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.83086258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 5.08947498 |
| 2 | MP0003136_yellow_coat_color | 3.75463209 |
| 3 | MP0001188_hyperpigmentation | 3.72481393 |
| 4 | MP0009379_abnormal_foot_pigmentation | 3.58579628 |
| 5 | MP0005409_darkened_coat_color | 3.44544242 |
| 6 | MP0006292_abnormal_olfactory_placode | 3.37365836 |
| 7 | MP0001986_abnormal_taste_sensitivity | 3.03493534 |
| 8 | MP0003880_abnormal_central_pattern | 2.96655165 |
| 9 | MP0000015_abnormal_ear_pigmentation | 2.95199414 |
| 10 | MP0008004_abnormal_stomach_pH | 2.82225667 |
| 11 | MP0004381_abnormal_hair_follicle | 2.72916377 |
| 12 | MP0005174_abnormal_tail_pigmentation | 2.67336180 |
| 13 | MP0000372_irregular_coat_pigmentation | 2.55780496 |
| 14 | MP0002876_abnormal_thyroid_physiology | 2.33248242 |
| 15 | MP0005075_abnormal_melanosome_morpholog | 2.25567741 |
| 16 | MP0010094_abnormal_chromosome_stability | 2.20498517 |
| 17 | MP0009785_altered_susceptibility_to | 2.02250461 |
| 18 | MP0006036_abnormal_mitochondrial_physio | 2.00469890 |
| 19 | MP0002751_abnormal_autonomic_nervous | 2.00210165 |
| 20 | MP0006035_abnormal_mitochondrial_morpho | 1.93378655 |
| 21 | MP0001984_abnormal_olfaction | 1.92684199 |
| 22 | MP0008260_abnormal_autophagy | 1.90689113 |
| 23 | MP0006276_abnormal_autonomic_nervous | 1.89846554 |
| 24 | MP0003724_increased_susceptibility_to | 1.88372852 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 1.80640629 |
| 26 | MP0000465_gastrointestinal_hemorrhage | 1.77709727 |
| 27 | MP0002638_abnormal_pupillary_reflex | 1.75071822 |
| 28 | MP0002735_abnormal_chemical_nociception | 1.74391124 |
| 29 | MP0008057_abnormal_DNA_replication | 1.69831185 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.68937420 |
| 31 | MP0005410_abnormal_fertilization | 1.68198293 |
| 32 | MP0008872_abnormal_physiological_respon | 1.66239632 |
| 33 | MP0001905_abnormal_dopamine_level | 1.64005298 |
| 34 | MP0001835_abnormal_antigen_presentation | 1.61343258 |
| 35 | MP0004510_myositis | 1.59159648 |
| 36 | MP0002095_abnormal_skin_pigmentation | 1.58849256 |
| 37 | MP0000358_abnormal_cell_content/ | 1.57582541 |
| 38 | MP0005171_absent_coat_pigmentation | 1.56120859 |
| 39 | MP0000343_altered_response_to | 1.54865534 |
| 40 | MP0005671_abnormal_response_to | 1.54623152 |
| 41 | MP0008789_abnormal_olfactory_epithelium | 1.53412454 |
| 42 | MP0002398_abnormal_bone_marrow | 1.51156139 |
| 43 | MP0001968_abnormal_touch/_nociception | 1.47253708 |
| 44 | MP0000566_synostosis | 1.46512650 |
| 45 | MP0008058_abnormal_DNA_repair | 1.45528035 |
| 46 | MP0002160_abnormal_reproductive_system | 1.43438852 |
| 47 | MP0004147_increased_porphyrin_level | 1.42883229 |
| 48 | MP0009764_decreased_sensitivity_to | 1.42678476 |
| 49 | MP0004957_abnormal_blastocyst_morpholog | 1.39287373 |
| 50 | MP0003077_abnormal_cell_cycle | 1.31630400 |
| 51 | MP0003111_abnormal_nucleus_morphology | 1.29871339 |
| 52 | MP0003693_abnormal_embryo_hatching | 1.28482422 |
| 53 | MP0002736_abnormal_nociception_after | 1.28398760 |
| 54 | MP0002272_abnormal_nervous_system | 1.28256780 |
| 55 | MP0000681_abnormal_thyroid_gland | 1.27970739 |
| 56 | MP0002102_abnormal_ear_morphology | 1.26913818 |
| 57 | MP0003718_maternal_effect | 1.26344316 |
| 58 | MP0000689_abnormal_spleen_morphology | 1.26103498 |
| 59 | MP0008932_abnormal_embryonic_tissue | 1.25297391 |
| 60 | MP0003828_pulmonary_edema | 1.25213177 |
| 61 | MP0001790_abnormal_immune_system | 1.24424432 |
| 62 | MP0005387_immune_system_phenotype | 1.24424432 |
| 63 | MP0002277_abnormal_respiratory_mucosa | 1.23729433 |
| 64 | MP0004142_abnormal_muscle_tone | 1.23726880 |
| 65 | MP0002132_abnormal_respiratory_system | 1.23554605 |
| 66 | MP0005025_abnormal_response_to | 1.23436211 |
| 67 | MP0003786_premature_aging | 1.21763377 |
| 68 | MP0009333_abnormal_splenocyte_physiolog | 1.21159203 |
| 69 | MP0005646_abnormal_pituitary_gland | 1.18794246 |
| 70 | MP0003879_abnormal_hair_cell | 1.17986698 |
| 71 | MP0005645_abnormal_hypothalamus_physiol | 1.14172533 |
| 72 | MP0000049_abnormal_middle_ear | 1.14002486 |
| 73 | MP0005000_abnormal_immune_tolerance | 1.12967680 |
| 74 | MP0004782_abnormal_surfactant_physiolog | 1.12334417 |
| 75 | MP0001929_abnormal_gametogenesis | 1.10844502 |
| 76 | MP0002722_abnormal_immune_system | 1.09587661 |
| 77 | MP0003195_calcinosis | 1.09387321 |
| 78 | MP0010155_abnormal_intestine_physiology | 1.09310217 |
| 79 | MP0002419_abnormal_innate_immunity | 1.09293248 |
| 80 | MP0002429_abnormal_blood_cell | 1.09157281 |
| 81 | MP0005499_abnormal_olfactory_system | 1.08642688 |
| 82 | MP0005394_taste/olfaction_phenotype | 1.08642688 |
| 83 | MP0000026_abnormal_inner_ear | 1.07991427 |
| 84 | MP0000716_abnormal_immune_system | 1.07183393 |
| 85 | MP0002210_abnormal_sex_determination | 1.06519597 |
| 86 | MP0003763_abnormal_thymus_physiology | 1.04413566 |
| 87 | MP0002184_abnormal_innervation | 1.03573818 |
| 88 | MP0001845_abnormal_inflammatory_respons | 1.02835625 |
| 89 | MP0000230_abnormal_systemic_arterial | 1.01223021 |
| 90 | MP0003221_abnormal_cardiomyocyte_apopto | 1.01168424 |
| 91 | MP0003938_abnormal_ear_development | 1.00037931 |
| 92 | MP0005058_abnormal_lysosome_morphology | 0.99841101 |
| 93 | MP0009763_increased_sensitivity_to | 0.99753328 |
| 94 | MP0008995_early_reproductive_senescence | 0.99726169 |
| 95 | MP0004270_analgesia | 0.99616632 |
| 96 | MP0002067_abnormal_sensory_capabilities | 0.98528202 |
| 97 | MP0000631_abnormal_neuroendocrine_gland | 0.98519678 |
| 98 | MP0001529_abnormal_vocalization | 0.98395464 |
| 99 | MP0002734_abnormal_mechanical_nocicepti | 0.96855232 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.96290517 |
| 101 | MP0001963_abnormal_hearing_physiology | 0.96131440 |
| 102 | MP0003646_muscle_fatigue | 0.96123585 |
| 103 | MP0006082_CNS_inflammation | 0.95971134 |
| 104 | MP0001542_abnormal_bone_strength | 0.95546834 |
| 105 | MP0009046_muscle_twitch | 0.94629821 |
| 106 | MP0002177_abnormal_outer_ear | 0.94431371 |
| 107 | MP0003303_peritoneal_inflammation | 0.94036968 |
| 108 | MP0005389_reproductive_system_phenotype | 0.91970166 |
| 109 | MP0002723_abnormal_immune_serum | 0.91806851 |
| 110 | MP0000703_abnormal_thymus_morphology | 0.91751765 |
| 111 | MP0009745_abnormal_behavioral_response | 0.91589347 |
| 112 | MP0002009_preneoplasia | 0.91350093 |
| 113 | MP0005408_hypopigmentation | 0.91158980 |
| 114 | MP0003011_delayed_dark_adaptation | 0.90981176 |
| 115 | MP0002405_respiratory_system_inflammati | 0.90939478 |
| 116 | MP0002420_abnormal_adaptive_immunity | 0.89809938 |
| 117 | MP0003186_abnormal_redox_activity | 0.89523308 |
| 118 | MP0001819_abnormal_immune_cell | 0.88074626 |
| 119 | MP0003315_abnormal_perineum_morphology | 0.87615078 |
| 120 | MP0005310_abnormal_salivary_gland | 0.87380872 |
| 121 | MP0001970_abnormal_pain_threshold | 0.86587832 |
| 122 | MP0003436_decreased_susceptibility_to | 0.85980697 |
| 123 | MP0001919_abnormal_reproductive_system | 0.84338453 |
| 124 | MP0009697_abnormal_copulation | 0.82682362 |
| 125 | MP0005379_endocrine/exocrine_gland_phen | 0.82515373 |
| 126 | MP0001853_heart_inflammation | 0.81004150 |
| 127 | MP0005084_abnormal_gallbladder_morpholo | 0.80818772 |
| 128 | MP0002452_abnormal_antigen_presenting | 0.80800065 |
| 129 | MP0002019_abnormal_tumor_incidence | 0.79326561 |
| 130 | MP0002752_abnormal_somatic_nervous | 0.78894659 |
| 131 | MP0001486_abnormal_startle_reflex | 0.78521563 |
| 132 | MP0003950_abnormal_plasma_membrane | 0.78200768 |
| 133 | MP0002163_abnormal_gland_morphology | 0.78015463 |
| 134 | MP0006054_spinal_hemorrhage | 0.77745071 |
| 135 | MP0001764_abnormal_homeostasis | 0.77572445 |
| 136 | MP0000653_abnormal_sex_gland | 0.77505640 |
| 137 | MP0003638_abnormal_response/metabolism_ | 0.77051319 |
| 138 | MP0001800_abnormal_humoral_immune | 0.77032942 |
| 139 | MP0001502_abnormal_circadian_rhythm | 0.76450385 |
| 140 | MP0003698_abnormal_male_reproductive | 0.76106803 |
| 141 | MP0008873_increased_physiological_sensi | 0.75870488 |
| 142 | MP0005266_abnormal_metabolism | 0.75012629 |
| 143 | MP0002090_abnormal_vision | 0.72832446 |
| 144 | MP0000313_abnormal_cell_death | 0.72618412 |
| 145 | MP0005397_hematopoietic_system_phenotyp | 0.72316363 |
| 146 | MP0001545_abnormal_hematopoietic_system | 0.72316363 |
| 147 | MP0008875_abnormal_xenobiotic_pharmacok | 0.71963267 |
| 148 | MP0002557_abnormal_social/conspecific_i | 0.70466571 |
| 149 | MP0008007_abnormal_cellular_replicative | 0.70359173 |
| 150 | MP0003806_abnormal_nucleotide_metabolis | 0.69245268 |
| 151 | MP0008877_abnormal_DNA_methylation | 0.68760195 |
| 152 | MP0008569_lethality_at_weaning | 0.68417500 |
| 153 | MP0000685_abnormal_immune_system | 0.67260849 |
| 154 | MP0004742_abnormal_vestibular_system | 0.67258803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Petechiae (HP:0000967) | 6.14952035 |
| 2 | Prolonged bleeding time (HP:0003010) | 5.90691982 |
| 3 | Type I transferrin isoform profile (HP:0003642) | 5.36513715 |
| 4 | Menorrhagia (HP:0000132) | 4.84930293 |
| 5 | Hypothermia (HP:0002045) | 4.82614781 |
| 6 | Purpura (HP:0000979) | 4.78446704 |
| 7 | Reduced antithrombin III activity (HP:0001976) | 4.70364367 |
| 8 | Increased mean platelet volume (HP:0011877) | 4.41607695 |
| 9 | Abnormal platelet volume (HP:0011876) | 4.17375578 |
| 10 | Epistaxis (HP:0000421) | 3.74699709 |
| 11 | Abnormal glycosylation (HP:0012345) | 3.71255131 |
| 12 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.71255131 |
| 13 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.71255131 |
| 14 | Abnormal protein glycosylation (HP:0012346) | 3.71255131 |
| 15 | Gingival bleeding (HP:0000225) | 3.48993970 |
| 16 | Hepatocellular necrosis (HP:0001404) | 3.31709927 |
| 17 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.29452902 |
| 18 | Dyschromatopsia (HP:0007641) | 3.23805870 |
| 19 | Impaired platelet aggregation (HP:0003540) | 3.21191442 |
| 20 | Abnormal platelet function (HP:0011869) | 3.21191442 |
| 21 | 3-Methylglutaconic aciduria (HP:0003535) | 3.19647987 |
| 22 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.15387080 |
| 23 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.11569562 |
| 24 | Mitochondrial inheritance (HP:0001427) | 3.06310198 |
| 25 | Renal Fanconi syndrome (HP:0001994) | 3.02662911 |
| 26 | Increased hepatocellular lipid droplets (HP:0006565) | 2.95263937 |
| 27 | Upper limb muscle weakness (HP:0003484) | 2.92954352 |
| 28 | Absent/shortened dynein arms (HP:0200106) | 2.88408642 |
| 29 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.88408642 |
| 30 | Thyroid-stimulating hormone excess (HP:0002925) | 2.88401372 |
| 31 | Abnormal number of erythroid precursors (HP:0012131) | 2.86385071 |
| 32 | Acute necrotizing encephalopathy (HP:0006965) | 2.85995270 |
| 33 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.81661296 |
| 34 | Hepatic necrosis (HP:0002605) | 2.79510729 |
| 35 | Nonprogressive disorder (HP:0003680) | 2.77227257 |
| 36 | Hyperlipoproteinemia (HP:0010980) | 2.77195165 |
| 37 | Type 2 muscle fiber atrophy (HP:0003554) | 2.75732554 |
| 38 | True hermaphroditism (HP:0010459) | 2.69093206 |
| 39 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.65543547 |
| 40 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.65543547 |
| 41 | Increased IgM level (HP:0003496) | 2.63978578 |
| 42 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.62680432 |
| 43 | Lipid accumulation in hepatocytes (HP:0006561) | 2.59008101 |
| 44 | Severe visual impairment (HP:0001141) | 2.57208345 |
| 45 | Abnormality of lateral ventricle (HP:0030047) | 2.53898783 |
| 46 | Increased CSF lactate (HP:0002490) | 2.51818070 |
| 47 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.51054519 |
| 48 | Abnormality of secondary sexual hair (HP:0009888) | 2.47371262 |
| 49 | Abnormality of the axillary hair (HP:0100134) | 2.47371262 |
| 50 | Generalized aminoaciduria (HP:0002909) | 2.43576797 |
| 51 | Nausea (HP:0002018) | 2.43527866 |
| 52 | Acanthocytosis (HP:0001927) | 2.43444067 |
| 53 | Optic disc pallor (HP:0000543) | 2.42645954 |
| 54 | Abnormal ciliary motility (HP:0012262) | 2.40028035 |
| 55 | Poikilocytosis (HP:0004447) | 2.39035937 |
| 56 | Parakeratosis (HP:0001036) | 2.37778373 |
| 57 | Exertional dyspnea (HP:0002875) | 2.35527344 |
| 58 | Albinism (HP:0001022) | 2.33663657 |
| 59 | Aplastic anemia (HP:0001915) | 2.28780380 |
| 60 | Abnormal spermatogenesis (HP:0008669) | 2.27928241 |
| 61 | Muscle fiber atrophy (HP:0100295) | 2.25136538 |
| 62 | Abnormality of renal resorption (HP:0011038) | 2.24284112 |
| 63 | Abnormality of magnesium homeostasis (HP:0004921) | 2.24161775 |
| 64 | Progressive macrocephaly (HP:0004481) | 2.23555357 |
| 65 | Split foot (HP:0001839) | 2.22200393 |
| 66 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.21240851 |
| 67 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.21223020 |
| 68 | Pancreatic fibrosis (HP:0100732) | 2.20927586 |
| 69 | Anhidrosis (HP:0000970) | 2.20682899 |
| 70 | Pancytopenia (HP:0001876) | 2.19035882 |
| 71 | Degeneration of anterior horn cells (HP:0002398) | 2.15229705 |
| 72 | Abnormality of the anterior horn cell (HP:0006802) | 2.15229705 |
| 73 | Tinnitus (HP:0000360) | 2.14599524 |
| 74 | Recurrent abscess formation (HP:0002722) | 2.14370175 |
| 75 | Conjunctival telangiectasia (HP:0000524) | 2.13681859 |
| 76 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.11619124 |
| 77 | Attenuation of retinal blood vessels (HP:0007843) | 2.11206712 |
| 78 | Respiratory difficulties (HP:0002880) | 2.10553196 |
| 79 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.10404853 |
| 80 | Birth length less than 3rd percentile (HP:0003561) | 2.08032468 |
| 81 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.07996163 |
| 82 | Obstructive lung disease (HP:0006536) | 2.06227348 |
| 83 | Chronic obstructive pulmonary disease (HP:0006510) | 2.06227348 |
| 84 | Focal motor seizures (HP:0011153) | 2.05647084 |
| 85 | IgG deficiency (HP:0004315) | 2.05573268 |
| 86 | Acute encephalopathy (HP:0006846) | 2.05317196 |
| 87 | Microvesicular hepatic steatosis (HP:0001414) | 2.04448865 |
| 88 | Patchy hypopigmentation of hair (HP:0011365) | 2.04022747 |
| 89 | Optic nerve hypoplasia (HP:0000609) | 2.03388196 |
| 90 | Encephalitis (HP:0002383) | 2.02725543 |
| 91 | Medial flaring of the eyebrow (HP:0010747) | 2.01937503 |
| 92 | Cerebral edema (HP:0002181) | 2.01702338 |
| 93 | Poor head control (HP:0002421) | 2.00723544 |
| 94 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.00651150 |
| 95 | Dry hair (HP:0011359) | 2.00440579 |
| 96 | Meningitis (HP:0001287) | 2.00280042 |
| 97 | Abnormality of the labia minora (HP:0012880) | 2.00272511 |
| 98 | Abnormal pupillary function (HP:0007686) | 1.99689027 |
| 99 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.98501630 |
| 100 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.98501630 |
| 101 | Increased serum lactate (HP:0002151) | 1.98009487 |
| 102 | Febrile seizures (HP:0002373) | 1.97686996 |
| 103 | Short tibia (HP:0005736) | 1.97047634 |
| 104 | Abnormality of alanine metabolism (HP:0010916) | 1.96336850 |
| 105 | Hyperalaninemia (HP:0003348) | 1.96336850 |
| 106 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.96336850 |
| 107 | Paralysis (HP:0003470) | 1.95804155 |
| 108 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.95704854 |
| 109 | Stomatitis (HP:0010280) | 1.95636902 |
| 110 | Renal tubular dysfunction (HP:0000124) | 1.95591975 |
| 111 | Postnatal microcephaly (HP:0005484) | 1.94899299 |
| 112 | Decreased central vision (HP:0007663) | 1.92838234 |
| 113 | Increased intramyocellular lipid droplets (HP:0012240) | 1.91529718 |
| 114 | Pancreatic cysts (HP:0001737) | 1.91168205 |
| 115 | Increased density of long bones (HP:0006392) | 1.91040256 |
| 116 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.90957642 |
| 117 | Retinal dysplasia (HP:0007973) | 1.90620130 |
| 118 | Exercise intolerance (HP:0003546) | 1.88087888 |
| 119 | Mediastinal lymphadenopathy (HP:0100721) | 1.87698446 |
| 120 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.87573326 |
| 121 | Autoimmune hemolytic anemia (HP:0001890) | 1.86595356 |
| 122 | Abnormal hair whorl (HP:0010721) | 1.84999552 |
| 123 | Hyperglycinemia (HP:0002154) | 1.84138306 |
| 124 | Azoospermia (HP:0000027) | 1.83206433 |
| 125 | Abnormality of the prostate (HP:0008775) | 1.82469920 |
| 126 | Microretrognathia (HP:0000308) | 1.81240011 |
| 127 | Polyphagia (HP:0002591) | 1.80447666 |
| 128 | White forelock (HP:0002211) | 1.80375545 |
| 129 | Hepatosplenomegaly (HP:0001433) | 1.79274521 |
| 130 | Neutropenia (HP:0001875) | 1.77425402 |
| 131 | Abnormality of dental color (HP:0011073) | 1.77036205 |
| 132 | Lactic acidosis (HP:0003128) | 1.76471414 |
| 133 | Prolonged partial thromboplastin time (HP:0003645) | 1.75633612 |
| 134 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.74087862 |
| 135 | Abnormality of the columella (HP:0009929) | 1.73389295 |
| 136 | Myelodysplasia (HP:0002863) | 1.73095815 |
| 137 | Nephrogenic diabetes insipidus (HP:0009806) | 1.72903188 |
| 138 | Myositis (HP:0100614) | 1.72656439 |
| 139 | Recurrent bacterial skin infections (HP:0005406) | 1.72524831 |
| 140 | Median cleft lip (HP:0000161) | 1.71211823 |
| 141 | Vacuolated lymphocytes (HP:0001922) | 1.70024671 |
| 142 | Agnosia (HP:0010524) | 1.69746042 |
| 143 | Abnormality of macrophages (HP:0004311) | 1.69323746 |
| 144 | Optic neuritis (HP:0100653) | 1.68563488 |
| 145 | Retrobulbar optic neuritis (HP:0100654) | 1.68563488 |
| 146 | Abnormal auditory evoked potentials (HP:0006958) | 1.68189910 |
| 147 | Male pseudohermaphroditism (HP:0000037) | 1.66962642 |
| 148 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.66365454 |
| 149 | Molar tooth sign on MRI (HP:0002419) | 1.64989935 |
| 150 | Abnormality of midbrain morphology (HP:0002418) | 1.64989935 |
| 151 | Hypomagnesemia (HP:0002917) | 1.64672949 |
| 152 | Reticulocytopenia (HP:0001896) | 1.64655729 |
| 153 | Concave nail (HP:0001598) | 1.64392514 |
| 154 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.63559882 |
| 155 | Agammaglobulinemia (HP:0004432) | 1.62967888 |
| 156 | Chromsome breakage (HP:0040012) | 1.60658938 |
| 157 | Acute hepatic failure (HP:0006554) | 1.59646530 |
| 158 | Lethargy (HP:0001254) | 1.58678038 |
| 159 | Lissencephaly (HP:0001339) | 1.57310710 |
| 160 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.56615294 |
| 161 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.56615294 |
| 162 | X-linked dominant inheritance (HP:0001423) | 1.56120444 |
| 163 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.55156328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.07402860 |
| 2 | TNIK | 4.53656549 |
| 3 | MUSK | 4.14596289 |
| 4 | EIF2AK1 | 4.13821959 |
| 5 | STK16 | 3.50244433 |
| 6 | TAOK3 | 2.92967204 |
| 7 | TRIM28 | 2.70646535 |
| 8 | EIF2AK3 | 2.64359966 |
| 9 | MKNK2 | 2.37813089 |
| 10 | PRPF4B | 2.24849707 |
| 11 | MAP2K7 | 2.17796082 |
| 12 | IRAK4 | 2.10202638 |
| 13 | VRK2 | 2.04344087 |
| 14 | MAP3K12 | 1.97081871 |
| 15 | NLK | 1.93069948 |
| 16 | YES1 | 1.89177599 |
| 17 | MKNK1 | 1.82557603 |
| 18 | EIF2AK2 | 1.76534565 |
| 19 | PIM2 | 1.71841128 |
| 20 | BMPR2 | 1.70319946 |
| 21 | ADRBK2 | 1.68067474 |
| 22 | MARK3 | 1.59709278 |
| 23 | MAP4K2 | 1.57779646 |
| 24 | SRPK1 | 1.52733658 |
| 25 | IRAK3 | 1.52267113 |
| 26 | ARAF | 1.44288853 |
| 27 | MAP3K14 | 1.41541121 |
| 28 | NME2 | 1.40366349 |
| 29 | TEC | 1.38421965 |
| 30 | TXK | 1.35453102 |
| 31 | PNCK | 1.33342347 |
| 32 | BMPR1B | 1.28926810 |
| 33 | BRSK2 | 1.27840420 |
| 34 | PLK3 | 1.22464156 |
| 35 | CLK1 | 1.19420456 |
| 36 | CDK19 | 1.17845216 |
| 37 | MAPK13 | 1.17561988 |
| 38 | MAP3K5 | 1.15870826 |
| 39 | GRK7 | 1.14150630 |
| 40 | VRK1 | 1.13616164 |
| 41 | CAMKK2 | 1.11609638 |
| 42 | RIPK4 | 1.10048240 |
| 43 | MST4 | 1.05765646 |
| 44 | STK3 | 1.02268688 |
| 45 | IKBKE | 1.00402259 |
| 46 | BMX | 0.96674034 |
| 47 | RAF1 | 0.96540174 |
| 48 | PBK | 0.96495555 |
| 49 | BLK | 0.95359231 |
| 50 | NEK1 | 0.94632397 |
| 51 | AKT3 | 0.94127473 |
| 52 | KIT | 0.93748134 |
| 53 | GRK6 | 0.91321404 |
| 54 | CDC7 | 0.90433003 |
| 55 | ZAK | 0.89305807 |
| 56 | BCKDK | 0.88019246 |
| 57 | TSSK6 | 0.83102165 |
| 58 | IKBKB | 0.82848689 |
| 59 | BRAF | 0.81750139 |
| 60 | PLK4 | 0.81523784 |
| 61 | MAPKAPK5 | 0.79114306 |
| 62 | STK24 | 0.79102870 |
| 63 | CDK3 | 0.78435591 |
| 64 | SIK3 | 0.78338994 |
| 65 | TAOK1 | 0.76354001 |
| 66 | ERBB3 | 0.75340177 |
| 67 | BTK | 0.75183895 |
| 68 | PDK2 | 0.75019206 |
| 69 | NEK6 | 0.73144310 |
| 70 | FES | 0.72817527 |
| 71 | PAK1 | 0.72503866 |
| 72 | IRAK1 | 0.72344434 |
| 73 | TLK1 | 0.72240259 |
| 74 | ILK | 0.71771340 |
| 75 | PLK1 | 0.71765912 |
| 76 | PINK1 | 0.71322738 |
| 77 | STK39 | 0.70129498 |
| 78 | SGK2 | 0.69579326 |
| 79 | DYRK2 | 0.68811239 |
| 80 | IRAK2 | 0.68744114 |
| 81 | TAF1 | 0.64963347 |
| 82 | KSR1 | 0.64903685 |
| 83 | MAPK15 | 0.63206360 |
| 84 | OXSR1 | 0.62227953 |
| 85 | SYK | 0.61586738 |
| 86 | TNK2 | 0.58602875 |
| 87 | BCR | 0.57242941 |
| 88 | PTK2B | 0.56711209 |
| 89 | PLK2 | 0.56710877 |
| 90 | RPS6KC1 | 0.55889609 |
| 91 | RPS6KL1 | 0.55889609 |
| 92 | STK4 | 0.54979297 |
| 93 | CSNK1A1L | 0.54043707 |
| 94 | LYN | 0.53971010 |
| 95 | CAMK1 | 0.53005787 |
| 96 | MELK | 0.52855411 |
| 97 | MYLK | 0.52747903 |
| 98 | CSF1R | 0.52723511 |
| 99 | WEE1 | 0.52691382 |
| 100 | HCK | 0.52565564 |
| 101 | RPS6KA6 | 0.52540987 |
| 102 | NTRK3 | 0.52465305 |
| 103 | GRK5 | 0.51548470 |
| 104 | CCNB1 | 0.51547254 |
| 105 | ADRBK1 | 0.51382408 |
| 106 | CAMK2B | 0.51244209 |
| 107 | NME1 | 0.51216458 |
| 108 | DAPK3 | 0.50810882 |
| 109 | WNK3 | 0.50660524 |
| 110 | BUB1 | 0.50372452 |
| 111 | SGK223 | 0.50196350 |
| 112 | SGK494 | 0.50196350 |
| 113 | TGFBR1 | 0.48379671 |
| 114 | MAP3K3 | 0.48142978 |
| 115 | FRK | 0.47432593 |
| 116 | NUAK1 | 0.47356997 |
| 117 | GRK1 | 0.47159954 |
| 118 | MAP3K9 | 0.46153496 |
| 119 | DMPK | 0.43751585 |
| 120 | MAPKAPK3 | 0.43340282 |
| 121 | CDK8 | 0.42686262 |
| 122 | TESK2 | 0.42589249 |
| 123 | TIE1 | 0.42435943 |
| 124 | MAPK4 | 0.42330298 |
| 125 | ATR | 0.42232362 |
| 126 | MAP2K6 | 0.39328859 |
| 127 | PIM1 | 0.38566855 |
| 128 | CSNK2A1 | 0.37279878 |
| 129 | CAMK2D | 0.37053892 |
| 130 | CAMK2A | 0.36614436 |
| 131 | DYRK3 | 0.36025336 |
| 132 | PRKCE | 0.35250878 |
| 133 | MATK | 0.34924732 |
| 134 | CSNK1G3 | 0.34345314 |
| 135 | UHMK1 | 0.33775782 |
| 136 | CSNK1G1 | 0.33032851 |
| 137 | CAMK2G | 0.32311662 |
| 138 | FGR | 0.30690235 |
| 139 | LCK | 0.30250560 |
| 140 | AURKA | 0.30165058 |
| 141 | TAOK2 | 0.29684487 |
| 142 | ACVR1B | 0.29299551 |
| 143 | EPHA4 | 0.28414779 |
| 144 | RPS6KB1 | 0.28042953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 3.10189162 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.07398088 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.01724012 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.94745161 |
| 5 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.41524799 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.14200027 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.09330920 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.09225568 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.06131844 |
| 10 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.02478459 |
| 11 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.98116090 |
| 12 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.89805299 |
| 13 | DNA replication_Homo sapiens_hsa03030 | 1.84451584 |
| 14 | Basal transcription factors_Homo sapiens_hsa03022 | 1.83794096 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.76428637 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.74946011 |
| 17 | Huntingtons disease_Homo sapiens_hsa05016 | 1.71345255 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.71105514 |
| 19 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.68328674 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.64893629 |
| 21 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.64005909 |
| 22 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.62535863 |
| 23 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.61291571 |
| 24 | Phototransduction_Homo sapiens_hsa04744 | 1.58588232 |
| 25 | Base excision repair_Homo sapiens_hsa03410 | 1.57302720 |
| 26 | Platelet activation_Homo sapiens_hsa04611 | 1.56182711 |
| 27 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.51213024 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.48455715 |
| 29 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.47274160 |
| 30 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.47067296 |
| 31 | Cell cycle_Homo sapiens_hsa04110 | 1.42970776 |
| 32 | RNA transport_Homo sapiens_hsa03013 | 1.41392100 |
| 33 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.40086616 |
| 34 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.39118587 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.38003419 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.30149309 |
| 37 | Purine metabolism_Homo sapiens_hsa00230 | 1.29239920 |
| 38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.28763801 |
| 39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.27596856 |
| 40 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.24865651 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17929716 |
| 42 | Nicotine addiction_Homo sapiens_hsa05033 | 1.16029403 |
| 43 | Asthma_Homo sapiens_hsa05310 | 1.15511956 |
| 44 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.14921548 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.14153995 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.13823380 |
| 47 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.13597927 |
| 48 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.12759322 |
| 49 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.12051662 |
| 50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.08533517 |
| 51 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.08512448 |
| 52 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.08453652 |
| 53 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.08020985 |
| 54 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.07614964 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.04834084 |
| 56 | Olfactory transduction_Homo sapiens_hsa04740 | 1.01844176 |
| 57 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.01564489 |
| 58 | Mismatch repair_Homo sapiens_hsa03430 | 1.01267105 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 1.00277145 |
| 60 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.96951456 |
| 61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.96849495 |
| 62 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.94529471 |
| 63 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.94213298 |
| 64 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.94109035 |
| 65 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.94071833 |
| 66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.90527393 |
| 67 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.89669325 |
| 68 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.87938699 |
| 69 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.87398732 |
| 70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.85623171 |
| 71 | Taste transduction_Homo sapiens_hsa04742 | 0.84259454 |
| 72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.81206838 |
| 73 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.79501938 |
| 74 | Phagosome_Homo sapiens_hsa04145 | 0.79400527 |
| 75 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.79100037 |
| 76 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.78358278 |
| 77 | RNA degradation_Homo sapiens_hsa03018 | 0.78242773 |
| 78 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.76836534 |
| 79 | Measles_Homo sapiens_hsa05162 | 0.73450062 |
| 80 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.72001303 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.69241403 |
| 82 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.68986850 |
| 83 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.65992126 |
| 84 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65603849 |
| 85 | Spliceosome_Homo sapiens_hsa03040 | 0.64767107 |
| 86 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.63495205 |
| 87 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.63074297 |
| 88 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.62985923 |
| 89 | Histidine metabolism_Homo sapiens_hsa00340 | 0.62368448 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61635471 |
| 91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61173653 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.61111541 |
| 93 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.55615322 |
| 94 | Malaria_Homo sapiens_hsa05144 | 0.53413441 |
| 95 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.53137559 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52354667 |
| 97 | Leishmaniasis_Homo sapiens_hsa05140 | 0.51594878 |
| 98 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51069116 |
| 99 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.49397603 |
| 100 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.49204625 |
| 101 | Peroxisome_Homo sapiens_hsa04146 | 0.48994500 |
| 102 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.48745843 |
| 103 | Hepatitis B_Homo sapiens_hsa05161 | 0.48558785 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.48073684 |
| 105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47378237 |
| 106 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.47226227 |
| 107 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.46988296 |
| 108 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46863321 |
| 109 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.46794996 |
| 110 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.45344132 |
| 111 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.45212285 |
| 112 | Apoptosis_Homo sapiens_hsa04210 | 0.44060028 |
| 113 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.43121289 |
| 114 | Morphine addiction_Homo sapiens_hsa05032 | 0.42079203 |
| 115 | Pertussis_Homo sapiens_hsa05133 | 0.41753299 |
| 116 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.40324335 |
| 117 | Retinol metabolism_Homo sapiens_hsa00830 | 0.39880653 |
| 118 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.39134532 |
| 119 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.38918591 |
| 120 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.37723172 |
| 121 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.36683264 |
| 122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35078143 |
| 123 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35059923 |
| 124 | Tuberculosis_Homo sapiens_hsa05152 | 0.34425564 |
| 125 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.34284126 |
| 126 | Alcoholism_Homo sapiens_hsa05034 | 0.33996476 |
| 127 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33062267 |
| 128 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.32654579 |
| 129 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.32580729 |
| 130 | Sulfur relay system_Homo sapiens_hsa04122 | 0.29906556 |
| 131 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.29206072 |
| 132 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.28330064 |
| 133 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.28168221 |

